Ferrer-Mayorga et al thus demonstrated that Wnt3a, a ligand highly expressed in CRC, enhanced the expression of the marker ACTA2/α-SMA in human colon fibroblasts [48]. This evidence concerns the gene ACTA2 and colorectal carcinoma.